VENMAX DRUGS AND PHARMACEUTICA - Share Price & Details
Peer Comparison
About VENMAX DRUGS AND PHARMACEUTICA
Company Updates
Quarterly Table
| Metrics | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|
| Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.3 |
|---|
| Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.5 | 0.7 | 0.5 |
|---|
| Operating Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | -0.5 | -0.2 |
|---|
| OPM % | 0% | 0% | 0% | 0% | -16.35% | -176.61% | -248.24% | -49.55% |
|---|
| Other Income | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 1.0 |
|---|
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
|---|
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
|---|
| Profit before tax | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | -0.3 | -0.5 | 0.9 |
|---|
| Tax % | 0% | 0% | -21.1% | -23.7% | 0% | 0% | 0% | 0% |
|---|
| Net Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | -0.5 | 0.8 |
|---|
| EPS in Rs | 0.03 | -0.05 | 0.06 | 0.09 | 0.02 | -0.58 | -0.95 | 0 |
|---|
No Consolidated data available.
Shareholding Distribution
Shareholding Pattern
Compounded Data
| Compounded Sales
Growth |
| 10 Years: |
-10% |
| 5 Years: |
12% |
| 3 Years: |
0% |
| TTM: |
0% |
| Compounded Profit
Growth |
| 10 Years: |
6% |
| 5 Years: |
14% |
| 3 Years: |
0% |
| TTM: |
-117% |
| Stock Price CAGR |
| 10 Years: |
21% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| 1 Year: |
0% |
| Compounded Sales
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| TTM: |
0% |
| Compounded Profit
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| TTM: |
0% |
| Stock Price CAGR |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| 1 Year: |
0% |
